Reed joined Accellix in September of 2019. He brings more than 25 years of diverse experience in the life science industry, and particularly the tools industry. Reed has extensive operational experience as well as commercial operations experience.
Early in his career, Reed gained 15 years of academic research experience in the molecular biology and developmental cardiology fields. He started at the University of California San Diego, as a research associate and later became a laboratory manager at Yale University.
Reed joined Invitrogen in 2005, where he supported the creation of a protein expression custom business. In 2007, he transitioned to the management side of the business and has held various roles culminating in leading the synthetic biology and sample preparation business units at Thermo Fisher. As part of his business leadership role, Reed managed nine global sites for the custom oligo business and has built of the GeneArt gene synthesis site in Pleasanton, California. In 2017 Reed took over leading product management for Twist Bioscience. During his time at Twist, Reed was pivotal in the scaling up of the business, leading to the IPO of the company in 2018.